Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 May;54(5):1742-8.
doi: 10.1128/AAC.01365-09. Epub 2010 Feb 16.

Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: a retrospective analysis

Scott T Micek  1 , Emily C Welch, Junaid Khan, Mubashir Pervez, Joshua A Doherty, Richard M Reichley, Marin H Kollef
Affiliations

Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: a retrospective analysis

Scott T Micek et al. Antimicrob Agents Chemother. 2010 May.

Abstract

The optimal approach for empirical antibiotic therapy in patients with severe sepsis and septic shock remains controversial. A retrospective cohort study was conducted in the intensive care units of a university hospital. The data from 760 patients with severe sepsis or septic shock associated with Gram-negative bacteremia was analyzed. Among this cohort, 238 (31.3%) patients received inappropriate initial antimicrobial therapy (IIAT). The hospital mortality rate was statistically greater among patients receiving IIAT compared to those initially treated with an appropriate antibiotic regimen (51.7% versus 36.4%; P < 0.001). Patients treated with an empirical combination antibiotic regimen directed against Gram-negative bacteria (i.e., beta-lactam plus aminoglycoside or fluoroquinolone) were less likely to receive IIAT compared to monotherapy (22.2% versus 36.0%; P < 0.001). The addition of an aminoglycoside to a carbapenem would have increased appropriate initial therapy from 89.7 to 94.2%. Similarly, the addition of an aminoglycoside would have increased the appropriate initial therapy for cefepime (83.4 to 89.9%) and piperacillin-tazobactam (79.6 to 91.4%). Logistic regression analysis identified IIAT (adjusted odds ratio [AOR], 2.30; 95% confidence interval [CI] = 1.89 to 2.80) and increasing Apache II scores (1-point increments) (AOR, 1.11; 95% CI = 1.09 to 1.13) as independent predictors for hospital mortality. In conclusion, combination empirical antimicrobial therapy directed against Gram-negative bacteria was associated with greater initial appropriate therapy compared to monotherapy in patients with severe sepsis and septic shock. Our experience suggests that aminoglycosides offer broader coverage than fluoroquinolones as combination agents for patients with this serious infection.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Percent of patients receiving inappropriate initial antimicrobial therapy (IIAT) according to combination antimicrobial treatment. Other combination antimicrobial therapy included double β-lactam (non-carbapenem) combinations (n = 33), β-lactam carbapenem combinations (n = 16), and combinations including either tigecycline or colistin (n = 5).
FIG. 2.
FIG. 2.
Hospital mortality and inappropriate initial antimicrobial therapy (IIAT) according to classification of infection source. (P < 0.001 for differences in hospital mortality and IIAT).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Al-Hasan, M. N., J. W. Wilson, B. D. Lahr, K. M. Thomsen, J. E. Eckel-Passow, E. A. Vetter, I. M. Tleyjeh, and L. M. Baddour. 2009. Beta-lactam and fluoroquinolone combination antibiotic therapy for bacteremia caused by gram-negative bacilli. Antimicrob. Agents Chemother. 53:1386-1394. - PMC - PubMed
    1. American Thoracic Society and Infectious Diseases Society of America. 2005. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am. J. Respir. Crit. Care Med. 171:388-416. - PubMed
    1. Angus, D. C., W. T. Linde-Zwirble, J. Lidicker, G. Clermont, J. Carcillo, and M. R. Pinsky. 2001. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29:1303-1310. - PubMed
    1. Arias, C. A., and B. E. Murray. 2009. Antibiotic-resistant bugs in the 21st century: a clinical super-challenge. N. Engl. J. Med. 360:439-443. - PubMed
    1. Barza, M., J. P. Ioannidis, J. C. Cappelleri, and J. Lau. 1996. Single or multiple daily doses of aminoglycosides: a meta-analysis. BMJ. 312:338-345. - PMC - PubMed

Publication types

MeSH terms